Low field MRI + Newphase + others diversifying third party sales via research making advances with $IBX nano particles
Its all about the printer ink, and the more outlets the better.
Low field portable MRI contrast,
New phase treatment,
others,
early detection MRX,
high field MRI contrast
How many more potential outlets ? Bob did say there were several research using our NP in the 55m Q&A.
Remember, just 100 magsense MRX doing just 3 tests per day, at $1500 per test = over 1m per year revenue.
ie, 100 magsense = 100m high margin revenue. (80%)
500 Magsense / MRI = 500m high margin revenue.
How much when New phase turn cancer into a chronic ailment that you just burn off at the macro level ?
How much when hand held MRX ? explosion in number of units owned by doctors offices.
How much when low Field portable MRI add to high field MRI ?
Its all about the growth in volumes in NP , and introducing new anti bodies to our NP to treat a wider brush of cancer and disease.
This is a multi Billion dollar bet over the next decade, on 2020 human trials, starts MRX early detection, and MRI high field contrast, while it has underlying support growing from third part sales that will potentially mature into growth markets.
The flagship is MRX, early detection saves lives. But you have to consider volume of sales from others.
Expand
